Janux Therapeutics Inc's total assets for Q1 2025 were $1.05B, a decrease of -1.01% from the previous quarter. JANX total liabilities were $38.30M for the fiscal quarter, a -1.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.